<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-77602</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Stevens-Johnson syndrome due to prednisone in a patient with systemic lupus erythematosus</dc:title>
<dc:description xml:lang="en">Stevens-Johnson syndrome is a systemic, mucocutaneous disease, frequently related to drugs. We present the case of a 35-year old patient with a diagnosis of systemic lupus erythematous treated with prednisone who developed a Stevens-Johnson syndrome and was treated with Methylprednisolone(AU)</dc:description>
<dc:creator>Tirado-Sánchez, Andrés</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de Stevens-Johnson es una enfermedad mucocutánea sistémica, asociada frecuentemente a medicamentos. Se presenta el caso de un paciente de 35 años de edad con diagnóstico de lupus eritematoso sistémico en tratamiento con prednisona, que desarrolló un síndrome de Stevens-Johnson que se trató con pulsos de metilprednisolona(AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);2(5): 275-277, sept.-oct. 2006. ilus</dc:source>
<dc:identifier>ibc-77602</dc:identifier>
<dc:title xml:lang="es">Síndrome de Stevens-Johnson secundario a prednisona en un paciente con lupus eritematoso sistémico</dc:title>
<dc:subject>^d331</dc:subject>
<dc:subject>^d32350^s22027</dc:subject>
<dc:subject>^d22622^s22020</dc:subject>
<dc:subject>^d8356^s22057</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7045^s22073</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d29589^s22036</dc:subject>
<dc:type>article</dc:type>
<dc:date>200610</dc:date>
</metadata>
</record>
</ibecs-document>
